Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Hadrup SR"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
O'Brien H; Achilles Therapeutics UK Ltd, United Kingdom., Salm M; Achilles Therapeutics UK Ltd, United Kingdom., Morton LT; Achilles Therapeutics UK Ltd, United Kingdom., Szukszto M; Research Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom., O'Farrell F; Achilles Therapeutics UK Ltd, United Kingdom., Boulton C; Research Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom., King L; Achilles Therapeutics UK Ltd, United Kingdom.; Research Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom., Bola SK; Research Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom., Becker PD; Achilles Therapeutics UK Ltd, United Kingdom., Craig A; Achilles Therapeutics UK Ltd, United Kingdom., Nielsen M; Technical University of Denmark, Lyngby, Denmark., Samuels Y; Weizmann Institute of Science, Rehovot, Israel., Swanton C; The Francis Crick Institute, London, United Kingdom., Mansour MR; Research Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom.; Department of Developmental Biology and Cancer, Great Ormond Street Institute of Child Health, UCL., Hadrup SR; Technical University of Denmark, Lyngby, Denmark., Quezada SA; Achilles Therapeutics UK Ltd, United Kingdom.; Research Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom.
Publikováno v:
PLoS computational biology [PLoS Comput Biol] 2024 Nov 11; Vol. 20 (11), pp. e1012511. Date of Electronic Publication: 2024 Nov 11 (Print Publication: 2024).
Autor:
Skadborg SK; Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Maarup S; Department of Oncology, DCCC Brain Tumor Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; National Center for Cancer Immune Therapy, CCIT-DK, Copenhagen University Hospital, Herlev, Denmark., Draghi A; National Center for Cancer Immune Therapy, CCIT-DK, Copenhagen University Hospital, Herlev, Denmark., Borch A; Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Hendriksen S; Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Mundt F; Novo Nordisk Foundation Center for Protein Research, CPR, University of Copenhagen, Copenhagen, Denmark., Pedersen V; Department of Oncology, DCCC Brain Tumor Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Pathology, The Bartholin Institute, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine and Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Mann M; Novo Nordisk Foundation Center for Protein Research, CPR, University of Copenhagen, Copenhagen, Denmark.; Research Department Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany., Christensen IJ; Department of Oncology, DCCC Brain Tumor Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Skjøth-Ramussen J; Department of Oncology, DCCC Brain Tumor Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Neurosurgery, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Yde CW; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Kristensen BW; Department of Oncology, DCCC Brain Tumor Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Pathology, The Bartholin Institute, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine and Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Poulsen HS; Department of Oncology, DCCC Brain Tumor Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Hasselbalch B; Department of Oncology, DCCC Brain Tumor Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Svane IM; National Center for Cancer Immune Therapy, CCIT-DK, Copenhagen University Hospital, Herlev, Denmark., Lassen U; Department of Oncology, DCCC Brain Tumor Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Hadrup SR; Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2024 Sep 03; Vol. 12 (9), pp. 1202-1220.
Autor:
Hulen TM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Friese C; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Kristensen NP; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Granhøj JS; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Borch TH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Peeters MJW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Hadrup SR; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Met Ö; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jul 18; Vol. 15, pp. 1462081. Date of Electronic Publication: 2024 Jul 18 (Print Publication: 2024).
Autor:
Mørk SK; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark sofie.kirial.moerk@regionh.dk., Skadborg SK; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Albieri B; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Draghi A; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Bol K; Medical Oncology, Radboudumc, Nijmegen, The Netherlands., Kadivar M; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Westergaard MCW; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Stoltenborg Granhøj J; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Borch A; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Petersen NV; Evaxion Biotech, Copenhagen, Denmark., Thuesen N; Evaxion Biotech, Copenhagen, Denmark., Rasmussen IS; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Andreasen LV; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Dohn RB; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Yde CW; Genomic Medicine, Rigshospitalet, Copenhagen, Denmark., Noergaard N; Department of Urology, Copenhagen University Hospital, Herlev, Denmark., Lorentzen T; Department of Gastroenterology, Copenhagen University Hospital, Herlev, Denmark., Soerensen AB; Evaxion Biotech, Copenhagen, Denmark., Kleine-Kohlbrecher D; Evaxion Biotech, Copenhagen, Denmark., Jespersen A; Evaxion Biotech, Copenhagen, Denmark., Christensen D; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Kringelum J; Evaxion Biotech, Copenhagen, Denmark., Donia M; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Hadrup SR; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Marie Svane I; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 May 23; Vol. 12 (5). Date of Electronic Publication: 2024 May 23.
Autor:
Kristensen NP; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Dionisio E; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Bentzen AK; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Tamhane T; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Kemming JS; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Nos G; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Voss LF; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Hansen UK; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Lauer GM; Liver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA., Hadrup SR; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark.
Publikováno v:
Science advances [Sci Adv] 2024 Apr 12; Vol. 10 (15), pp. eadm8951. Date of Electronic Publication: 2024 Apr 12.
Autor:
Borch A; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Carri I; Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, Buenos Aires, Argentina., Reynisson B; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Alvarez HMG; Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, Buenos Aires, Argentina., Munk KK; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Montemurro A; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Kristensen NP; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Tvingsholm SA; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Holm JS; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Heeke C; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Moss KH; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Hansen UK; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Schaap-Johansen AL; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Bagger FO; Center for Genomic Medicine, Copenhagen University Hospital, Copenhagen, Denmark., de Lima VAB; Department of Oncology, Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark., Rohrberg KS; Department of Oncology, Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark., Funt SA; Department of Medicine, Weill Cornell Medical College, New York, NY, United States., Donia M; National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., Svane IM; National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., Lassen U; Department of Oncology, Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark., Barra C; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Nielsen M; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.; Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, Buenos Aires, Argentina., Hadrup SR; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Apr 03; Vol. 15, pp. 1360281. Date of Electronic Publication: 2024 Apr 03 (Print Publication: 2024).
Autor:
Cavalluzzo B; Innovative Immunological Models Unit, Istituto Nazionale Tumori - IRCCS - 'Fond G. Pascale', Via Mariano Semmola, 52, Naples, Italy., Viuff MC; Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark., Tvingsholm SA; Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark., Ragone C; Innovative Immunological Models Unit, Istituto Nazionale Tumori - IRCCS - 'Fond G. Pascale', Via Mariano Semmola, 52, Naples, Italy., Manolio C; Innovative Immunological Models Unit, Istituto Nazionale Tumori - IRCCS - 'Fond G. Pascale', Via Mariano Semmola, 52, Naples, Italy., Mauriello A; Innovative Immunological Models Unit, Istituto Nazionale Tumori - IRCCS - 'Fond G. Pascale', Via Mariano Semmola, 52, Naples, Italy., Buonaguro FM; Molecular Biology and Viral Oncogenesis Unit, Istituto Nazionale Tumori - IRCCS - 'Fond G. Pascale', Naples, Italy., Tornesello ML; Molecular Biology and Viral Oncogenesis Unit, Istituto Nazionale Tumori - IRCCS - 'Fond G. Pascale', Naples, Italy., Izzo F; Hepatobiliary Surgical Oncology Unit, Istituto Nazionale Tumori - IRCCS - 'Fond. G. Pascale', Naples, Italy., Morabito A; Thoracic Medical Oncology, Istituto Nazionale Tumori - IRCCS - 'Fond G. Pascale', Naples, Italy., Hadrup SR; Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark., Tagliamonte M; Innovative Immunological Models Unit, Istituto Nazionale Tumori - IRCCS - 'Fond G. Pascale', Via Mariano Semmola, 52, Naples, Italy. m.tagliamonte@istitutotumori.na.it., Buonaguro L; Innovative Immunological Models Unit, Istituto Nazionale Tumori - IRCCS - 'Fond G. Pascale', Via Mariano Semmola, 52, Naples, Italy. l.buonaguro@istitutotumori.na.it.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 20; Vol. 43 (1), pp. 87. Date of Electronic Publication: 2024 Mar 20.
Autor:
Ryu H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Bi TM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Pulliam TH; Department of Medicine, Division of Dermatology, University of Washington, Seattle, WA, USA., Sarkar K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Church CD; Department of Medicine, Division of Dermatology, University of Washington, Seattle, WA, USA., Kumar N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Lab Medicine and Pathology, University of Washington, Seattle, WA, USA., Mayer-Blackwell K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Jani S; Department of Medicine, Division of Dermatology, University of Washington, Seattle, WA, USA; Department of Lab Medicine and Pathology, University of Washington, Seattle, WA, USA., Ramchurren N; Cancer Immunotherapy Trails Network, Fred Hutchinson Cancer Center, Seattle, WA, USA., Hansen UK; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Hadrup SR; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Fling SP; Cancer Immunotherapy Trails Network, Fred Hutchinson Cancer Center, Seattle, WA, USA., Koelle DM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Lab Medicine and Pathology, University of Washington, Seattle, WA, USA; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA; Benaroya Research Institute, Seattle, WA, USA., Nghiem P; Department of Medicine, Division of Dermatology, University of Washington, Seattle, WA, USA., Newell EW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Lab Medicine and Pathology, University of Washington, Seattle, WA, USA. Electronic address: enewell@fredhutch.org.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2024 Feb 20; Vol. 5 (2), pp. 101390. Date of Electronic Publication: 2024 Feb 09.